Phathom Pharmaceuticals Inc. (PHAT)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Avidity Partners Management

David Witzke And Michael Gregory

1,735,000 $18,425,700 +1% 0.59%
2. 1,650,000 $17,523,000 +29% 1.28%
3.
Propel Bio Management

Leen Kawas And Richard Kayne

869,927 $9,238,625 +97% 5.37%
4. 850,000 $9,027,000 1.21%
5.
Woodline Partners

Michael Rockefeller And Karl Kroeker

566,439 $6,015,582 -49% 0.05%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.80 2,500 Director 55,000 2023-11-08 Filing
$7.76 4,000 Director 52,500 2023-11-07 Filing
$8.04 1,000 Director 48,500 2023-11-06 Filing
$7.55 1,000 Director 23,500 2023-04-10 Filing
$8.26 10,000 Officer 99,567 2023-04-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$11.10 3,435 95,263 2024-04-08 Filing
$9.11 16,851 410,784 2024-03-22 Filing
$8.10 3,703,703 Large Shareholder 3,755,583 2024-01-24 Filing
$7.75 6,307 Officer 98,698 2024-01-19 Filing
$7.24 2,127 Officer 103,061 2023-11-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 10,109,279 $92,297,717 4.93%
2. 3,760,869 $34,336,734 11.59%
3. 3,496,808 $31,925,857 1.53%
4. 3,167,653 $28,920,672 0%
5. 2,678,891 $24,458,274 0%
News See All